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Abstract
Background: Gliomas are "intraparenchymally metastatic" tumors, invading the brain in a non-
destructive way that suggests cooperation between glioma cells and their environment. Recent
studies using an engineered rodent C6 tumor cell line have pointed to mechanisms of invasion that
involved gap junctional communication (GJC), with connexin 43 as a substrate. We explored
whether this concept may have clinical relevance by analyzing the participation of GJC in human
glioblastoma invasion.
Results: Three complementary in vitro assays were used: (i) seeding on collagen IV, to analyze
homocellular interactions between tumor cells (ii) co-cultures with astrocytes, to study
glioblastoma/astrocytes relationships and (iii) implantation into organotypic brain slice cultures,
that mimic the three-dimensional parenchymal environment. Carbenoxolone, a potent blocker of
GJC, inhibited cell migration in the two latter models. It paradoxically increased it in the first one.
These results showed that homocellular interaction between tumor cells supports intercellular
adhesion, whereas heterocellular glioblastoma/astrocytes interactions through functional GJC
conversely support tumor cell migration. As demonstrated for the rodent cell line, connexin 43
may be responsible for this heterocellular functional coupling. Its levels of expression, high in
astrocytes, correlated positively with invasiveness in biopsied tumors.
Conclusions: our results underscore the potential clinical relevance of the concept put forward
by other authors based on experiments with a rodent cell line, that glioblastoma cells use
astrocytes as a substrate for their migration by subverting communication through connexin 43-
dependent gap junctions.
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Background
Glioblastoma, the most aggressive primary brain tumor, is
invariably associated with profuse and long-distance inva-
sion of the brain parenchyma. Accordingly, this tumor has
been defined as "intraparenchymally metastatic" [1].
Intra-parenchymal dissemination is largely responsible
for systematic recurrence despite treatments [2], and poor
prognosis with a median survival time not exceeding one
year [3]. Preferential routes of long-distance dissemina-
tion have been identified, among which the basal lamina
of blood vessels and fiber tracts [1,4]. Numerous studies
have revealed mechanisms of invasion in those condi-
tions, specifying the molecular bases of glioma cells inter-
action with specific ligands of the brain extracellular
matrix, their proteolytic modification by glioma cells, and
the corresponding cellular receptors [2,5]. Less is known
about the mechanisms that underlie the migration of gli-
oma cells among neural cells, in the brain parenchyma,
despite its profuseness in the area that surrounds the
tumor mass, and its major role in recurrence.
We have undertaken to identify the mechanisms of this
particular type of glioma invasion, on the basis of the
hypothesis that cells in the brain parenchyma may play a
supportive role in this process. One key for the elabora-
tion of this working hypothesis has been the demonstra-
tion that this intra-parenchymal invasion occurs in a non-
destructive way (see refs and discussion in Bernstein,
1996), as this suggests that invading human glioblastoma
cells may establish relationships of cooperation with their
environment and in particular with resident brain cells.
We have focused our attention on gap junctions because
of two complementary reasons. First, evidence from
peripheral tumors such as melanoma has implicated gap
junctions in tumor cell migration [6]. Second, gap-junc-
tional communication via connexin 43 (Cx43) between
astrocytes and glioma cells has been demonstrated [7],
and linked to a phenotypic transformation of astrocyte
which may render the brain parenchyma permissive to gli-
oma invasion. In a recent study, Lin et al. have strongly
supported this hypothesis by establishing that non-migra-
tory rodent C6 tumor cells display a migratory behavior
following transplantation into the rat brain, when engi-
neered to synthesize Cx43 [8]. Although Cx43 was shown
to exert additional cell adhesion effects, the authors dem-
onstrated that promotion of migration was not associated
with this role but with the establishment of functional gap
junctional communication (GJC). Astrocytes -to which
glioblastoma cells are phenotypically most closely
related- are widely inter-connected through gap junctions,
formed predominantly by the protein Cx43 [9] and gli-
oma cells also express Cx43 [10-13].
Building up upon the concepts defined by Zhang et al.
(1999) and Lin et al. (2002), we have explored their clin-
ical relevance by looking at the ability of human glioblas-
toma cells to establish functional gap junctions with
astrocytes, and at the role that such functional interaction
may play in their migratory behavior. To observe and
quantify the migration of human glioblastoma cells in a
three-dimensional brain environment ex vivo, our analysis
has taken advantage of ISIS, the "intra-slice implantation
system" that we have recently developed [14], in addition
to in vitro glioma cell cultures and glioma/astroglial co-
cultures. The ISIS set-up allows the implantation not only
of human tumor cells but also of fragments of biopsied
glioblastoma into rodent brain slices maintained in cul-
ture [14,15]. It allows for long term analysis of glioma cell
migration in a three-dimensional organotypic environ-
ment that mimics that of the brain parenchyma and appli-
cation of pharmacological agents to disrupt GJC.
Results
Heterocellular coupling and migration of human 
glioblastoma cell lines
Heterocellular coupling was assessed in glioma-astrocytes
co-cultures, using the dual-label technique, in which gli-
oma cells were pre-labeled donors cells and astrocytes
potential recipient cells labeled through gap-junctional
diffusion of the dye. Heterocellular coupling was more
extensive for GL15 cells (heterocellular coupling astro-
cytes/glioma ratio: 4.05 ± 0.6 recipient astrocytes per one
GL15 donor cell) than for 8-MG cells (0.6 ± 0.2; p <
0.001) (Fig. 1A).
Analysis of tumor cells invasion was assessed in brain slice
cultures, in which both homocellular coupling (between
glioma cells) and heterocellular coupling with astrocytes
can occur. GL15 cells displayed a significantly higher inva-
sive potential than 8-MG cells [(S - S0) / S0 = 7.82 ± 0.68
vs. 2.67 ± 0.67, p < 0.001] (Fig. 1B).
Addition of CBX induced a significant decrease in the het-
erocellular coupling index of GL15 cells with astrocytes
(down to 1.89 ± 0.74; p < 0.001) in co-cultures (Fig. 2B)
whereas coupling was similar in control cultures either
untreated, or treated with the functionally inactive ana-
logue of CBX, GZA. Inhibition of GJC by CBX following
implantation of GL15 into brain slices, resulted in a sig-
nificant decrease in GL15 cells invasion into the brain
parenchyma. The surface ratio (S-S0) / S0 of migration was
reduced by inhibition of the gap junction function (5.59
± 0.49 for CBX-treated vs. 7.82 ± 0.70 in untreated con-
trols; p < 0.01) (Fig. 2C), as well as the number of GL15
cells that left the tumor mass (105 ± 6.3 cells/mm of
perimeter vs. 132 ± 7.2; p < 0.01) (Fig. 2D). There was no
difference between results obtained in the GZA and con-
trol groups. Those results were confirmed when migration
of glioma cells out of spheroids was analyzed over anBMC Cell Biology 2005, 6:7 http://www.biomedcentral.com/1471-2121/6/7
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astrocyte monolayer culture in a 42 hours-long time lapse
experiment (Fig. 2E).
In contrast, CBX treatment had no significant effect on 8-
MG migration, either in glioma-astrocytes co-cultures or
following implantation into brain slices (data not
shown).
Inhibition of GJC reduces invasion ability of cells either 
from human glioma xenografts maintained in nude mice or 
from fresh human glioma biopsies
The composite cellular content of glioma fragments and
the technical difficulty in maintaining cells alive after
seeding them in culture as cell suspensions, precluded
analysis of the functional coupling of tumors, either
maintained in nude mice or freshly biopsied. We, there-
fore, relied upon the effects of CBX to assess whether, sim-
ilarly to results obtained in established glioma cell lines,
inhibition of GJC may affect the migration of tumor cells
out of a fragment and into the neural parenchyma of a
brain slice.
Invasive capacities of the seven tumors maintained in
nude mice were quite heterogeneous. Three were mini-
mally invasive according to our criteria [total number of
cells that detached from the tumor mass was less than 15
cells and the distance of migration less than 50 µm (T3, T6
and T8)]. These three tumors were precisely the ones in
the series of 7 tumors to not exhibit any response to CBX
treatment (Table 1). Among tumors characterized as
"invasive" according to our criteria, CBX treatment signif-
icantly inhibited invasion in three (T2, T4 and T7), and
had no statistically significant effect in one (T1). Inhibi-
tion concerned both the surface ratio of migration (35 to
50% decrease) and the number of migratory cells (25% to
40% decrease) (Table 1). Treatment with the inactive ana-
logue GZA had no effect on migration as compared to
controls.
Heterocellular coupling of glioma cell lines, and migration assay in brain slice cultures Figure 1
Heterocellular coupling of glioma cell lines, and migration assay in brain slice cultures. A, heterocellular coupling 
between astrocytes and human glioma cell lines (using the preloading method, see also fig. 6A). In contrast to 8-MG cells, GL15 
cells established extensive GJC with normal astrocytes. Histograms represent mean heterocellular coupling indices (number of 
recipient astrocytes per double labeled tumor cell) of a minimum of three independent experiments (range 4 – 6; n= 120 to 
225 donor cells per group; ± SEM; ***, p < 0.001). B, 8-MG cells and GL15 cells migration in brain slice cultures. Histograms of 
the average migration indices showing that GL15 were more invasive than 8-MG cells (mean values ± SEM. ***, p < 0.001).
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Effects of inhibition of heterocellular coupling between GL15 cells and astrocytes Figure 2
Effects of inhibition of heterocellular coupling between GL15 cells and astrocytes. A, Photomicrographs in co-cul-
tures (preloading method) showing heterocellular coupling without (upper panel) or with addition of the inhibitor CBX. GL15 
donor cells pre-labeled with a non-diffusing membrane-bound dye (DiI, red) and loaded with a fluorescent gap junction-perme-
able dye (calcein, green) were seeded on a monolayer of unlabeled astrocytes. Functional heterocellular GJC is visualized as the 
transfer of calcein from DiI-labeled donor cells (small arrows) to surrounding recipients cells. Donors cells appear yellow 
because of the merge of red and green labeling. CBX reduced the number of calcein-containing (green) recipient astrocytes, 
(×200). B, Histograms representing mean values of a minimum of three independent runs as in A (range 4 – 6; n = 160 to 225 
donor cells per group ± SEM). (***, p < 0.001). C and D, histograms of the migration indices of GL15 in brain slices without or 
with CBX, illustrating decreased migration in the treated group (mean values ± SEM. **, p < 0.01). E, Cumulative migration 
indices plotted against time in co-cultures where GL15 cell spheroids were plated upon an astrocyte monolayer, without or 
with CBX; (S - S0) / S0 values were measured every 12 h, for 48 h. Integrated areas under the two curves in arbitrary units 
were compared, p < 0.0001.
Table 1: Cx43 expression and invasive capacity of gliomas maintained in nude mice
Controls CBX
Tumor Tumor§ Cx43 (S-S0)/S0 Cells/mm 
perimeter
(S-S0)/S0 Cells/mm 
perimeter
T1 TG-4-GEN +++ 1.15 ± 0.23 77 ± 9.4 1.05 ± 0.11 68 ± 5.6
T2 TG-1-HAM +++ 0.56 ± 0.05 81 ± 9.4 0.29 ± 0.08 *** 50 ± 7.5 *
T3 TG-7-ROM + 0a -0 a -
T4 TG-14-RAV +++ 1.11 ± 0.08 73 ± 6.7 0.71 ± 0.04 ** 54 ± 4.7 *
T6 TG-5-RAI +/- 0a -0 a -
T7 TG-14-CHA +++ 0.45 ± 0.08 48 ± 4.2 0.22 ± 0.01 *** 35 ± 4.4 *
T8 TG-20-THO +/- 0a -0 a -
a, cut off : a tumor which exhibited less than 15 migrating cells distance of migration, if any, less than 50 µm, was considered non invasive.
§ Xenograft tumor nomenclature as originally described by Leuraud et al (2003).
n = 7–10 per group and condition. ***, p < 0.001. **, p < 0.01, *, p < 0.05
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In order to test whether the results obtained with experi-
mental gliomas could be extrapolated to native tumors,
the migration potentials of biopsies from 4 human high
grade gliomas (HG) were studied in brain slice culture,
with or without addition of CBX or GZA. Overall, CBX
treatment reduced migration indices of these four tumors
by 30% (range 20 to 50%; p < 0.05 unpaired t test and
Mann & Whitney – Table 2); this was the most pro-
nounced for HG-23 (p < 0.02, Fig. 3A).
Cx43 expression in glioma cells
In order to investigate whether Cx43 was instrumental in
the establishment of functional coupling between glioma
cells and astrocytes, Cx43 expression was analyzed in gli-
oma cells from GBM cell lines and fresh human biopsies
used in previous experiments. We chose to focus on Cx43
because it is the major Cx in astrocytes and is expressed by
glioma cells [10-13].
Table 2: Cx43 expression and invasive capacities of human biopsed gliomass
Controls CBX
Tumor Cx43-IR (S-S0)/S0 (S-S0)/S0
HG-18 + 4.89 ± 0.85 (n = 6) 3.63 ± 0.86 (n = 6)
HG-19 + 8.12 ± 0.83 (n = 9) 6.69 ± 0.88 (n = 7)
HG-22 + 3.64 ± 0.66 (n = 9) 2.92 ± 0.21 (n = 8)
HG-23 +++ 5.48 ± 0.85 (n = 6) 2.92 ± 0.47 (n = 6)
IR: immunoreactivity
Inhibition of gap junctional communication in biopsied human gliomas Figure 3
Inhibition of gap junctional communication in biopsied human gliomas. A. Vimentin immunostaining of the biopsied 
human glioblastoma HG-23 7 days after implantation into a cultured brain slice without (left panel) or with (right panel) CBX. 
Note the inhibition of cell migration when GJC is blocked. B, Connexin 43 immunocytochemistry (DAB, counterstained with 
hematoxylin) in two glioblastomas showing either moderate (HG-22) or abundant (HG-23) expression of the protein (×200). 
At the cellular level (inserts, ×1000), staining is dot-like or linear, predominantly at the membrane.
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In agreement with previous studies [16], three isoforms of
Cx43 could be separated on SDS-PAGE and visualized by
immunoblotting as three distinct bands in control
astroglial primary cultures: Cx43-NP, a non-phosphor-
ylated isoform, Cx43-P1 and Cx43-P2, the two phospho-
rylated isoforms of the protein (Fig. 4). The Cx43-P1
isoform was prominent and Cx43-P2 and Cx43-NP iso-
forms were equally present (Fig. 4). As for invasive poten-
tial, Cx43 expression pattern was different in the two GBM
cell lines with the GL15 cells exhibiting a three-fold higher
concentration of the Cx43-P1 as compared to 8-MG cells
(p < 0.001; Fig; 4A).
Histological analysis of Cx43 immunoreactivity in brain
slices implanted with GL15 cells, showed that the protein
was overexpressed in the tumor margin where glioma cells
and astrocytes processes were intimately apposed and
intermingled (Fig. 5). Confocal microscopy of brain slices
allowed us to identify regions of enhanced immunostain-
ing for Cx43 at the interface between GL15 cells and astro-
cytes, suggesting the existence of heterocellular gap
junctions (Fig. 5). Interestingly, these astrocytes displayed
a bipolar morphology that extended in arrays a long proc-
ess that paralleled the outward migrating cells. This was
not observed when 8-MG glioma cells were implanted.
A general expression of the P1 isoform was observed in
the seven tumors maintained in nude mice, and a variable
expression of the Cx43-NP isoform. The four invasive
tumors (T1, T2, T4 and T7) expressed abundantly both
Cx43 isoforms Cx43-NP and Cx43-P1, whereas the three
others (T3, T6 and T8) which were not invasive and did
not exhibit any response to CBX treatment, expressed
lower levels of Cx43-P1 isoform and did not present
detectable levels of Cx43-NP. (Fig. 4B). No expression of
Cx43-P2 was recorded.
The amount of tissue available for experimental analysis
did not allow us to carry out western blotting on freshly
biopsied tumor fragments. Thus Cx43 expression in the
human tumor biopsies was evaluated by immunohisto-
chemistry on paraffin embedded tissue section.
Cx43 immunostaining was seen in all 4 specimens. Stain-
ing was patchy, and both the intensity of staining and the
number of immunostained cells in patches differed from
one sample to another. In the typical case, a positive
microscopic field contained several strongly stained cells,
and several unequivocally labeled cells of lower intensity
(Fig. 3B). Homogenous fields of particularly strong
immunolabeling intensity was observed in the HG-23
specimen.
Homocellular coupling and migration of human 
glioblastoma cell lines
We have next evaluated homocellular coupling between
glioma cells by the scrape loading method, in which
homocellular coupling is demonstrated by the diffusion
of the dye from mechanically lesioned cells to their neigh-
bors in a monolayer culture. Assay revealed extensive cou-
pling of GL15 (homocellular coupling index: 63.75 ± 4.4
%), comparable to that displayed by astrocytes in parallel
control experiments (60 ± 5.2%), whereas 8-MG cells
were only weakly coupled (12.7 ± 1.87 %; p < 0.001 vs.
GL15), a result in keeping with their low level of Cx43
expression. Homocellular coupling of all cell types was
strongly affected by addition of the gap junctional blocker
CBX: down to 7.4 ± 1.3 % for astrocytes (p < 0.001), to
1.97 ± 0.47 for GL15 (p < 0.001) and to 2.2 ± 0.47 for 8-
MG cells (p < 0.001) (Fig. 6), whereas GZA had no effect.
Connexin 43 expression in glioma cells Figure 4
Connexin 43 expression in glioma cells. A, Western 
blot analysis of Cx43 expression in cell lines GL15 (lanes 1 
and 2) and 8-MG (lanes 4 and 5), and in primary mouse 
astrocytes (lane 3). Three isoforms of Cx43 were detected in 
normal astrocytes, that corresponded to two phosphor-
ylated (Cx43-P1 and Cx43-P2) and one non-phosphorylated 
(Cx43-NP) isoforms. GL15 cells exhibited higher level of 
Cx43 protein than 8 MG cells. B, Western blot analysis of 
Cx43 expression in seven human gliomas maintained in nude 
mice (T1 to T8). All tumors expressed one phosphorylated 
isoform. In addition, the non-phosphorylated isoform was 
detected in 4 tumor samples (T1, T2, T4 and T7). Tubulin 
was used as internal control The gels shown, are representa-
tive of a minimum of three independent experiments.
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Cx43 immunoreactivity in brain slice culture injected with GL15 glioma cells Figure 5
Cx43 immunoreactivity in brain slice culture injected with GL15 glioma cells. A, 3D projection of 15 consecutive 
confocal sections (0.5 µm) (×630), showing cooperation between migrating GL15 glioma cells (vimentin imunostaining, blue) 
with host astrocytes of the brain slice (GFAP immunostaining, red). Cx43 protein (green), is overexpressed by both tumor 
cells and astrocytes at the tumor margin where their processes are entwined. B, a single confocal section and two orthogonal 
projections (right and lower margins) corresponding to the overlayed perdendicular line. Enlarged view, of area boxed in B 
shows punctuate Cx43 immunoreactivity corresponding to gap junction plaques, at the interface of glioma cells and astrocytes 
strongly suggesting formation of heterocellular gap junctions. Note astrocyte morphologic changes which extend bipolar proc-
esses parallel to the long axes of the tumor cells
B
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Homocellular coupling in human glioma cell lines using the scrape loading method Figure 6
Homocellular coupling in human glioma cell lines using the scrape loading method. A, Dye coupling in absence 
(upper row) or presence (lower row) of the gap junctional blocker CBX. After scraping, injured cells were loaded with Lucifer 
Yellow (LY) and Rhodamin Dextran, and GJC was assessed by the number of neighboring cells that secondarily acquired green 
fluorescence. Left panel, confluent monolayer of GL15 cells in phase contrast. Right panel, centrifugal (left to right) diffusion of 
the dye tracer LY (green) from initially loaded injured cells (yellow, because of the merge of red and green) in the same monol-
ayer. (×100). B, histogram representing the homocellular coupling indices (mean values ± SEM) from 4 to 6 independent cul-
tures for each condition and cell type (astrocytes, GL15 or 8-MG). Homocellular coupling index = % labeled cells out of a total 
of ~400–800 analyzed cells per cell culture. Addition of CBX resulted in a dramatic decrease of the homocoupling in all cases 
***, p < 0.001.
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Migration assay of glioma cell lines on collagen IV Figure 7
Migration assay of glioma cell lines on collagen IV. A, vimentin-immunostained GL15 and 8-MG spheroids, after 4 days 
of culture on collagen IV without (upper row) and with (lower row) addition of CBX, (x50). B, (S - S0) / S0 ratios (mean values 
± SEM) obtained from 10 to 30 spheroids per group and condition. Addition of CBX enhanced spheroid disintegration and 
centrifugal dispersion of migrating cells. ***, p < 0.001.
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To ensure that CBX-induced decreased migration of GL15
cells was mediated by the effect of the compound on gap
junction communication, rather than more generally on
the phenotype of tumor cells, analysis of tumor cell
migration was performed in experimental conditions in
which only homocellular coupling could exist, i.e. after
seeding of glioma spheroids on a collagen IV matrix. Sur-
prisingly, when homocellular coupling between tumor
cells was inhibited by CBX, both tumor cell lines dis-
played a significant increase in migration out of the sphe-
roids [(S-S0) / S0 = 55 ± 4.1 and 25.4 ± 5.25 for GL15 and
8 MG, respectively, p < 0.001 vs. untreated in both cases]
(Fig 7).
Induction of glioma cell migration in vivo by 
overexpression of Cx43
In order to validate further the hypothesis of a role of GJC
formed by Cx43 in tumor cell migration, we have used a
technique adapted from that used by Lin et al. (2002) [8].
C6 tumor cells have been genetically engineered by trans-
fection, using a plasmid containing a fusion gene encod-
ing GFP attached to the carboxyl terminus of Cx43. The
gap junctions formed by this chimeric protein were dye-
permeable [17]. C6 cells are known to proliferate without
migrating out of the tumor mass, following implantation
into the rat brain, and do not express a significant amount
of Cx43. By transplanting mixed population of native and
In vivo parenchymal invasion of C6 glioma cells overexpressing the fusion protein GFP-Cx43 Figure 8
In vivo parenchymal invasion of C6 glioma cells overexpressing the fusion protein GFP-Cx43. A, vimentin-immu-
nolabeled C6 glioma cells (red) 8 days after striatal injection in the nude mice brain. C6 cells overexpressing the Cx43-GFP 
protein in green (arrow heads), are preferentially located at the tumor margin and display an invasive phenotype (×100). B, 
Microscopic field of the area boxed in A, at a higher magnificence (×200). C, D, confocal section (1 µm) of the border of 
another tumor showing invasive C6-Cx43-GFP cells at the tumor periphery migrating out. C6 cells which did not express 
Cx43-GFP protein, only labeled in red for vimentin remain in the tumor mass. E, is the overlay of the two channels. Migrating 
C6-Cx43-GFP cells appear yellow because of the merge of red and green. Dashed lines indicate the extremity of the tumor mass. 
Scale bar, 25 µm. tm, tumor mass.
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GFP-Cx43-transfected cells, we explored the capacity for
the latter to display specifically a migratory behavior.
Indeed, GFP-Cx43 expressing C6 cells were preferentially
located at the periphery of the tumor mass and some were
even observed scattered in the surrounding brain paren-
chyma, strongly suggesting a migratory behavior (Fig. 8).
This was not observed with C6-GFP cells which were, as
classically described, only present in the tumor mass.
Discussion
The main result of this study is the demonstration that
functional GJC between tumor cells and host astrocytes is
instrumental in the invasion of the brain parenchyma by
human glioblastoma cells. Establishment of functional
coupling between those two cell populations may be
mediated by the gap junction protein Cx43 as ability of
glioblastoma cells of various origins to migrate out of the
tumor bulk into the brain parenchyma, appeared related
to the level of Cx43 expression. In support of this hypoth-
esis, overexpression of a fusion Cx43-GFP gene construct
triggered a migratory behavior in otherwise non-infiltra-
tive C6 glioma cells implanted into the brain. The similar-
ities between those results and mechanisms of neural
precursor cell migration during embryonic development
suggest that glioma cells may subvert and take advantage
of a physiological mechanism of cell migration into the
brain. In contrast, homocellular interaction between gli-
oma cells through gap junctions hampers their dissemina-
tion out of the tumor mass, pointing to an additional role
for gap junctions, in cell-to-cell adhesion.
Over the past decade, studies on GJC in gliomas have
mainly addressed its role in uncontrolled cell prolifera-
tion [18-20], by analogy with epithelial cancers in which
a low level of connexin expression is a sign of profoundly
perturbed tissue homeostasis and malignant evolution
[21]. The notion that, in gliomas, GJC may also favor
migration draws scientific argumentation from embryol-
ogy and from observations that other neurectodermal
tumors such as melanoma need to establish GJC with host
cells in order to migrate out [6]. This concept has been
strongly supported recently by the demonstration that a
C6 rodent glioma cell line that had been genetically engi-
neered to express Cx43 displayed a migratory behavior
following transplantation into the rat brain [8]. This phe-
nomenon was the more striking that the value of the
rodent C6 cell line as an experimental model for glioblas-
toma has always been questioned because it did not
reproduce the infiltrative phenotype which is a major
characteristic of the human brain tumor. The induction of
C6 migration was related to the establishment of func-
tional GJC between glioma cells and host astrocytes
through homotypic Cx43-Cx43 gap junctions.
Several lines of evidence drawn from our results converge
to indicate that this concept is clinically relevant, as GJC
with astrocytes also plays a role in the migration of brain
tumor cells for human glioblastomas. Experimental
results obtained here with native human glioblastoma
cells of various origins, can indeed be interpreted as a
demonstration of a similar role for GJC. First, pharmaco-
logical blockade of GJC by the specific inhibitor CBX [22]
had negative effects on tumor cell migration, whereas its
inactive analogue GZA [23] did not. Second, the gap
junction protein Cx43, which is overexpressed by reactive
astrocytes in the margin of glioblastomas [10], was also
expressed by all studied human tumors, including biopsy
specimens, providing a molecular basis for the potential
formation of homotypic heterocellular gap junctions.
Last, close membrane appositions at regions of
reinforcement of Cx43 immunostaining, suggesting inter-
cellular contacts between astrocytes and glioma cells
migrating out of a tumor spheroid or the body mass, were
observed in co-cultures of glioma cells on an astroglial
monolayer, as well as following implantation of tumors
into brain slices maintained in organotypic cultures.
The pharmacological approach used here had both advan-
tages and drawbacks, which should be indicated as they
may limit the conclusions to be drawn. The main
advantage of that technique is the fact that it allowed us to
study GJC inhibition in fresh tumor samples, in which
biological properties and diversity of glioblastoma cells
are well preserved, in contrast to the clonal selection and
genetic variation that are commonly observed with cells
lines. Conversely, we probably introduced some
biological variability in the experimental system. This
may be relevant to the fact that GJC inhibition with CBX
did not abolish but rather reduced the rate of human gli-
oma cell migration in our study, whereas Lin et al. (2002)
obtained an "all-or-nothing" effect following genetic engi-
neering of the C6 line. The partial effect on migration
observed here may be due to the partial pharmacological
inhibition consistent with the results of other studies
[24,25] that demonstrated that CBX only reduced GJC by
50%. Alternatively, glioblastoma cell migration into the
brain parenchyma does not relate exclusively to cell-to-
cell interaction with astrocytes. Interactions between
tumor cell and matrix components (reviewed by Giese et
al., 2003) [5] are also major actors in glioma cell migra-
tion, and they are most likely not effected by inhibition of
GJC, at least not directly. The use of a pharmacological
compound also leads to questions about specificity. Vari-
ous compounds used to block GJC have additional non-
specific and toxic effects, among which halotane, octanol
or acidifying agents. CBX has been shown to be nontoxic
and has no effect on cell proliferation, total protein syn-
thesis or cell viability [23,26,27]. This is ascribed, by some
authors, to its mode of action, through direct binding onBMC Cell Biology 2005, 6:7 http://www.biomedcentral.com/1471-2121/6/7
Page 12 of 17
(page number not for citation purposes)
connexon particles [22]. We have checked the specificity
of the GJC effects via different experimental ways, includ-
ing a systematic negative control with glycyrrhyzic acid
(GZA), the CBX precursor which only differs from it by its
inability to disrupt GJC. CBX and its inactive analog GZA
are known to both interact with mineralocorticoïd and
glucocorticoïd receptors (see discussion in [28]), but these
receptors do not mediate CBX-decreased GJC [23]. We
also tested CBX effect on cell apoptosis, cell proliferation
or cell viability in our conditions. No significant effect was
observed. Although it has been reported that Cx43 may
induce cell growth [18,29], we did not observe any effect
of CBX on cell proliferation. It is interesting to mention
that CBX-decreased GJC is mainly due to alteration of gap
junction channel permeability, whereas Cx overexpres-
sion is sufficient to regulate cell growth [20,30]. As an
interesting positive control of the specificity of the effects
recorded in co-cultures and following implantation of
tumor cells into brain slices, we have observed an oppo-
site effect of CBX on cell migration when only homocellu-
lar interaction between glioblastoma cells was concerned
(on collagen IV). Altogether, these results support the con-
clusion that non-specific pharmacological effects, if any,
did not alter results of our study in a consequential
manner.
Levels of Cx43 expression were positively related to gli-
oma invasiveness. Analysis of Cx43 expression by western
blot allowed detection of two distinct isoforms of the
Cx43 protein, Cx43-P and Cx43-NP. Both isoforms were
detected in the four highly invasive tumors (T1, T2, T4,
T7), whereas the three minimally invasive tumors (T3, T6,
T8) displayed no detectable levels of Cx43-P isoform. The
presence of both Cx43 isoforms strongly correlated with
the invasive capacities of the tumor. However, whether
the migratory capacity may depend on the overall levels of
expression, and/or upon the concomitant presence of
both Cx43 isoforms is, at this stage, a matter of specula-
tion. Published data on the association of either isoform
with the functional state of gap junctions are conflicting.
Phosphorylation of Cx43 either on serine or tyrosine resi-
dues has been reported to disrupt GJC (for review see
[31,32]). This could in part explain why T3, T6 and T8
tumors, which only displayed the phosphorylated iso-
form -the inactive isoform of Cx43-, were non-invasive
tumors. However, the reverse association between Cx43
dephosphorylation and GJC inactivation has been
suggested in astrocytes [33]. Further biochemical analysis
of Cx43 isoforms function in these cells may reveal
whether the pattern of Cx43 isoform expression is
involved in the invasive process and how this pattern can
be altered by specific phosphorylation. On the other
hand, it cannot be excluded that the abundance of both -
P and -NP isoforms in migrating tumors simply relates to
a dynamic turnover of connexons between the cytoplasm
(Cx43-NP) and the cell membrane of a migrating cell,
where Cx43-P may participate in short-lived contacts with
host astrocytes [21]. Recent data have shown that CBX
itself did not have any effect on the phosphorylation pat-
tern of Cx43 [34].
In the biopsy specimens, levels of Cx43 expression were
different from one tumor to another, and from one zone
to another within a specimen, in agreement with results
reported by other authors [10-13]. Interestingly, the high-
est expression of Cx43 was seen in HG-23, the tumor in
which migration was the most substantially inhibited by
CBX. In addition, transfection of C6 glioma cells with a
Cx43 protein fused to a green fluorescent protein allowed
us to trace C6-Cx43 cells after intrastriatal stereotactic
implantation. Consistent with results of Lin et al (2002)
and [35], only C6-Cx43 cells switched to an invasive phe-
notype providing a direct evidence of the positive correla-
tion between glioma cells Cx43 expression and invasive
potential. We hypothesize that Cx43 may favor glioma
cells migration by facilitating glioma cells to form gap
junction interactions with host astrocytes that will allow
them, through currently unknown molecular mecha-
nisms, to drag out from the tumor mass.
A peculiar morphological finding in this study was the
phenotypic alteration of astroglial processes around
tumors. Changes in the astroglial phenotype induced by
glioma cells through GJC have been observed by other
authors [7]. The ISIS protocol used here allowed us to gain
a comprehensive three-dimensional view of the astroglial
meshwork, and to identify the radial orientation of astro-
cytic processes toward the body of the tumors. This organ-
ization is reminiscent of the scaffolding of radial glial cells
observed in the developing neocortex in vivo [36]and in
vitro [37]. Radial glial cells extending long processes from
the ventricular zone to the cortical plate [36]communicate
with migrating neurons through Cx43 gap junctions [38-
40]. Although tentatively, we may therefore speculate that
astroglial Cx43 provide similarly support and guidance to
the migrating tumor cells. In the same way as immature
neuronal cells do [38,39,41], glioma cells may trigger the
phenotypic change of surrounding astrocytes into radial
glia-like cells, in order to make them suitable as a sub-
strate for migration.
The three different migration assays allowed us to explore
the importance of intercellular interactions between
migrating cells and cellular environment occurring during
invasion. We have shown that inhibition of homocellular
GJC in GL15 spheroids seeded on collagen IV (i.e. in the
absence of astrocytes), boosted glioma cell motility,
resulting in a higher centrifugal dispersion of cells. This
result is in keeping with that obtained by Lin et al (2002)
in an experiment in which Cx43 was shown to mediateBMC Cell Biology 2005, 6:7 http://www.biomedcentral.com/1471-2121/6/7
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glioma cell adherence and aggregation. However, acceler-
ated motility of GL15 glioma cells when CBX blocked
homocellular glioma/glioma GJC was not observed when
glioma cells additionally formed heterocellular GJC with
astrocytes, i.e. on astrocyte monolayer or in brain slices.
Quite the contrary, heterocellular glioma-astrocytes GJC
seemed to be necessary for the invasive process to occur
normally, as CBX significantly blocked it in those
conditions.
Conclusions
The purpose of our study was to determine whether the
concept that functional gap junctional communication
with host astrocytes facilitates invasion of malignant gli-
oma cells put forward by other authors on the basis of
experiments using a rodent glioma model (Lin et al,
2002), indeed apply to human glioblastoma and may, as
a consequence, bear clinical relevance. This has indeed
been clearly confirmed by the inhibitory effect of the spe-
cific GJC blocker, carbenoxolone, on the migration of
human glioblastoma cells. Results obtained ex vivo on dif-
ferent supports of migration point to a functional differ-
ence between homocellular (glioma-glioma) and
heterocellular (glioma-astrocytes) GJC. This may eventu-
ally be of prime therapeutic interest, by revealing mecha-
nisms by which glioma cells disengage themselves from
their neighbors in the tumor bulk, and establish new con-
tacts with host astrocytes in order to migrate away [2,7].
Methods
The role of GJC in human glioma invasion was investi-
gated in vitro using three different types of preparations,
namely glioblastoma cell lines, xenografts in nude mice,
and freshly biopsied tumors. Because of selection for gen-
otypes, the original cell heterogeneity of gliomas is
restricted in xenografts and absent from cell lines. These
models, therefore, do not fully reproduce the cell content
of  in vivo gliomas but, reciprocally, they present the
advantage of being homogenous, easy to handle, and to
allow analysis of large numbers of cells. ISIS uniquely per-
mits to study, in addition, the invasiveness of freshly
biopsied tumors with preserved cell repertoire. In those
conditions, however, investigation is limited by the
amount of available tissue.
Human glioma cells
The two human glioblastoma (GB) cell lines used in the
study, GL15 [42] and 8-MG [43] were grown as cell cul-
ture in glioma-cell medium: 50% minimum essential
medium (MEM) and 50% Dubelco Modified Eagle's
Medium (DMEM) complemented with 10% fetal calf
serum (ATGC Biotechnological, France), glutamine 2
mM, D-glucose 3.3 mM, Penicillin 100 UI/mL, Strepto-
mycin 100 µg/mL (all from Eurobio, France) at 37°C in a
5% CO2 humidified incubator. On confluence, cells were
trypsinized, centrifuged at 300 G for 10 minutes and
resuspended in 1 mL of glioma-cell medium. 5 × 105 cells
were seeded in 1.5% agar-coated flasks (25 cm3, Falcon,
France) for 7–10 days to obtain GL15 and 8-MG sphe-
roids. Spheroids with a diameter ranging from 50–100
µm were selected for migration assays.
Seven grade III-IV human glioma biopsies xenografted
and maintained subcutaneously in Swiss Nu/Nu  mice
(Charles River, France), kindly provided to us by Dr M-F.
Poupon and P. Leuraud [44], were used in this study. For
the sake of simplicity these tumors are referred to in the
text as T1, T2, T3, T4, T6, T7 and T8 (see table 1). Mice
were sacrificed when the tumor bulk reached a diameter
larger than 1 cm. The tumors were retrieved and immedi-
ately transferred in the glioma-cell medium. Areas of
necrosis and hemorrhage were identified under a micro-
scope and discarded. The remaining tissue was cut into
three fragments that were used as follows: -one was imme-
diately implanted into a healthy nude mouse, in order to
maintain the model; -a second one was immediately fro-
zen for Western Blot analyses; -the third one was cut into
smaller pieces for implantation into rodent brain slices
maintained in organotypic cultures (see below).
Finally, four fresh human biopsy specimens were
obtained from stereotactic or resection biopsies in the
operating room. All samples were retrieved by the neuro-
surgeon from areas of enhanced contrast on magnetic res-
onance imaging, which correspond to a hypercellular
zone on histological examination of the tumor. After
retrieval, samples were immediately transferred in glioma-
cell medium and prepared for implantation into brain
slices. Pathological analysis of the same tumors was
carried out in parallel on adjacent specimens; it systemat-
ically included immunohistochemistry for the connexin
protein Cx43 in addition to usual stains. According to the
WHO 2000 classification, these tumors were glioblasto-
mas in three cases, an anaplastic grade III astrocytoma in
one. For the sake of simplicity the generic term of glioblas-
toma will be used in the rest of the text.
Functional assessment of gap junctional communication
Functional assessment of gap junctional communication
(GJC) was performed on glioblastoma cell lines. Homo-
cellular GJC was determined by the scrape-loading/dye
transfer technique [45,46]. Briefly, either GL15, 8-MG or
astrocytic cell cultures were incubated for 10 minutes in
HEPES buffer solution (140 mM NaCl, 5.5 mM KCl, 1.8
mM CaCl2, 1 mM MgCl2 10 mM glucose and 10 mM
HEPES pH 7.3). Cells were then washed in a Ca2+-free
HEPES solution to prevent uncoupling. After scraping
with the razor blade cells were incubated in the same solu-
tion containing 1 mg/ml of Lucifer Yellow (LY) (Sigma,
France) and 1 mg/mL of Rhodamin Dextran 10,000 MVBMC Cell Biology 2005, 6:7 http://www.biomedcentral.com/1471-2121/6/7
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(Molecular Probes) for 1 minute. Dye transfer through
GJC was assessed 10 minutes after scraping, using an Axi-
oplan-2 microscope and appropriate filters (Carl Zeiss,
Inc; Oberkochen, Germany). Fluorescent and bright light
images digitized with a CoolSNAP camera (Ropper Scien-
tific; Tuscon, AZ) from every microscopic field were
merged, and the homocellular coupling index was calcu-
lated as the ratio of the number of LY-labeled cells to the
total number of cells.
Heterocellular GJC was evaluated in glioma/astroglial
cells co-cultures by a method adapted from Goldberg et al.
(1995) [27]. Tumor cells were loaded for 20 min with a
dual-label dye solution containing isotonic PBS-glucose
(0.3M), 5 µM Calcein-AM and 10 µM DiI (both from
Molecular Probes, France). They were then rinsed three
times with isotonic PBS-glucose 0.3M, trypsinized and
centrifuged. Five hundred Calcein/DiI-labeled cells
(donor cells) were seeded on an unlabeled confluent
astrocytic monolayer (recipient cells), and incubated at
37°C in a 5% CO2 humidified incubator for 20 h. Hete-
rocellular coupling was calculated as the ratio of recipient
cells (calcein-labeled astrocytes) to donor cells (Calcein/
DiI-labeled glioblastoma cells). It is important to under-
line that this technique is different from the scrape load-
ing method and uses another dye tracer to assess the gap
junctional coupling. Hence, their results cannot be readily
compared in quantitative terms.
Effects of inhibition of GJC were evaluated by treating the
cultures with carbenoxolone (CBX); controls received its
inactive analog, glycyrrhyzic acid (GZA) [23] (both from
Sigma, France). CBX is a widely used specific inhibitor of
GJC likely exerting its action by changing the conforma-
tion of gap-junction channels [22], while GZA has no
effect on GJC. CBX and GZA treatments were carried out
at a concentration of 30 µM. Cytotoxicity of these mole-
cules on the two glioblastoma cell lines and on astrocytes
had been tested in preliminary experiments. There was no
significant increase in the lactate dehydrogenase medium/
cell ratio for up to 7 days at the concentrations used (Cyto-
toxicity Detection Kit, Roche Molecular Biochemicals,
France).
Cell migration assays
Migration of glioblastoma cell lines was analyzed in three
different experimental in vitro set ups: on collagen IV-
coated cell culture dishes, after seeding on an astrocytic
monolayer culture, and following implantation into orga-
notypic brain slices (ISIS, Intra-Slice Implantation
System). Migration out of tumor fragments issued from
xenografted gliomas or from freshly biopsied specimens
were only studied using the ISIS method.
Migration of GL15 and 8 MG cells out of spheroids depos-
ited onto collagen-coated (0.5 µg/mL; Sigma, France) cell
culture dishes was analyzed over 4 days.
For astrocytic co-cultures, primary astrocyte cultures were
obtained from cerebral hemispheres of neonatal C57/bl6
mice (Charles River, France) as previously described [47].
Cells were grown in astrocyte medium: MEM (GIBCO,
France) complemented with 10% FCS (ATGC Biotechno-
logical, France), glutamine 2 mM, D-glucose 33 mM, Pen-
icillin 100 UI/mL, Streptomycin 100 µg/mL and amino
acids 0.5X (all from Eurobio, France). Medium was
changed every 3 days. On confluence, GL15 and 8-MG
spheroids were seeded on top of the astroglial monolayer,
and cultures were continued for 4 days.
The ISIS migration assay was carried out as described pre-
viously [14], using brain slices obtained from postnatal
day 6 C57/bl6 mice. Briefly, after decapitation the two
hemispheres were separated and 400 µm-thick coronal
slices were cut using a McIllwain tissue chopper (Mickle
Laboratory, England). Slices were transferred into brain
slices medium: MEM (GIBCO, France), 1 g/l D-glucose,
10% heat-inactivated fetal calf serum, 0.1 g/l transferrin,
16 µg/l putrescin, 40 µg/l N-selenium, 30 µg/l tri-iodothy-
ronin, 5 mg/l insulin, and 60 µg/l progesterone (all from
Sigma, France). Slices were separated and transferred onto
Millicell-CM membranes (Millipore, France). The Milli-
cell-CM membranes were kept in six-well plates, above 1
ml of brain slice medium. Slices were incubated at 37°C
in a humid atmosphere with 5% CO2. The medium was
changed three times a week. 24 hours after brain slice
preparation, GL15 and 8-MG spheroids or small frag-
ments of xenografted tumors and freshly biopsied speci-
mens were deposited onto the slice surface and gently
pushed with the tip of a needle, until the tumor tissue was
well enveloped by the parenchyma of the slice. Cultures
were maintained for 5 or 7 days for cell lines and tumor
fragments, respectively.
In all experimental conditions, effects of the blockade of
GJC were assessed using CBX (30 µM for collagen-coated
and astrocytic co-cultures; 60 µM for brain slice cultures, a
stronger dose because of the thinness of the slice), with
two negative controls: untreated and GZA supplemented
to the medium instead of CBX. These compounds were
added to the culture medium 24 h after glioma spheroid
or tumor implantation.
In vivo experiments
For a control experiment, we transfected the C6 glioma
cell line with a plasmid vector encoding either a green flu-
orescent protein (GFP) fused to the carboxyl terminus of
Cx43 [17] kindly provided by Dr P. Martin, or else only
GFP. C6-Cx43-GFP cells and C6-GFP control cells wereBMC Cell Biology 2005, 6:7 http://www.biomedcentral.com/1471-2121/6/7
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implanted into the striatum of nude mice (5. 104 cells in
1 µL) (n = 5). Mice were sacrificed at day 8 and perfused
with paraformaldehyde (4%) 8 days after implantation.
Brains were sectioned serially on cryostat at 30 µm thick-
ness as previously described [48].
Immunoblotting and immunohistochemistry
Immunoblot analysis for Cx43 was performed on cells
and tumor samples that were suspended in lysis buffer
containing Tris base 50 mM, pH 7.4, NaCl 150 mM, Tri-
ton X-100 0.5%, EDTA 1 mM, protease inhibitor cocktail
0.5% (Sigma, St. Quentin, France) and triturated to
homogeneity. Homogenates were centrifuged at 13,000 G
for 10 or 30 minutes (for cell lines and tumor samples,
respectively), and supernatants were aliquoted and stored
at -80°C. Total protein content was determined by the
Lowry method with bovine serum albumin as a standard.
Total protein (30 µg) was boiled for 5 min after addition
of 10% glycerol/5% mercaptoethanol and separated on
SDS-PAGE 12.5% gels, transferred on PVDF membrane
(Bio-RAD, France) under classical conditions [49] and
immunoblotted overnight at 4°C, using a polyclonal anti-
Cx43 antibody (1:500, Zymed, France). Bound primary
antibody was detected with a horseradish peroxydase-
coupled anti-rabbit antibody (1:5,000; Amersham Phar-
macia Biotech, France). In preliminary positive control
experiments, Cx43 was revealed as three bands of about
41, 43 and 45 kDa, representing three different isoforms
in heart sample. The two higher molecular mass bands
have been shown to correspond to phosphorylated forms
of the protein, and the 41 kDa migrating species to the
unphosphorylated form of the protein [16].
Immunohistochemistry was carried out on cell and slice
cultures and brain slices from in vivo experiments follow-
ing fixation using 4% paraformaldehyde in PBS at 4°C
(30 min for mono- and co-cultures, 4 h for ISIS). For flu-
orescent immunostaining, cultures were rinsed several
times in PBS, then incubated for 1 hour in PBS containing
10% normal horse or goat serum and 0.6% Triton X-100
(Sigma). They were incubated overnight at 4°C with mon-
oclonal antibodies against vimentin (1/400, Neo Markers,
France), or polyclonal antibodies against glial fibrillary
acidic protein-GFAP (1/100, Dako) or Green Fluorescent
Protein-GFP (1/200,. Molecular Probes). After 3 washes in
PBS, they were then incubated with a PBS solution con-
taining anti-rabbit or anti-mouse immunoglobulin conju-
gated either to fluorescein isothiocyanate-FITC, AMCA (1/
400; Vector, France), or to cyamidine-Cy3 (1/1000;
Jackson Immuno Research, France). For human biopsies,
immunocytochemical detection of Cx43 was carried out
on formalin-fixed, paraffin-embedded 5 µm sections.
Antigen-retrieval consisted in heating slides immersed in
citrate buffer (pH 6) in a microwave oven (3 × 5 min at
750 W). To block non-specific binding sites slides were
incubated in PBS containing 10% BSA. A primary polyclo-
nal antibody (Zymed) directed against the intracellular
portion of the Cx43 molecule was applied (1:200) to
sections overnight. Bound primary antibodies were
detected by a Vector Elite ABC kit (Vector Laboratories,
Burlingame, California) following the manufacturer's
instructions and using DAB as the chromogen. Slides were
lightly counterstained in Harris's hematoxylin. Negative
controls had the primary antibodies omitted. A specimen
of normal human cortex from epilepsy surgery showed
diffuse staining of astrocytic cells accentuated at perivas-
cular and superficial locations, corresponding to astro-
cytic endfeet and the glia limitans, respectively.
Quantification and statistical analysis
Fluorescent microscopy on a Zeiss Axioplan2 microscope
and image analysis using the KS.400 (3.0 version) soft-
ware were performed to quantify invasion of glioma cells,
according to techniques that have been detailed elsewhere
[14]. Two invasion parameters were assessed, (i) the max-
imum area of invasion, given as the ratio (S-S0) / S0, where
S is the maximum area containing migrating glioma cells
and S0 is the initial tumoral mass area, this ratio compen-
sating for the heterogeneous sizes of implanted spheroids
and tumor fragments, and (ii) the number of invading
cells (cells/mm of S0  perimeter). For collagen-coated
migration assay and astrocytic co-cultures, only the maxi-
mum area of invasion was assessed. The statistical signifi-
cance was evaluated using Mann & Whitney test and
Student unpaired t test.
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